Aug. 12, 2004 — The U.S. Food and Drug Administration (FDA) has approved atorvastatin calcium to reduce the risk of heart attack in patients with normal to mildly elevated cholesterol levels and other ...

NEW YORK--(BUSINESS WIRE)--Pfizer announced today that the U.S. Food and Drug Administration (FDA) has approved Lipitor® (atorvastatin calcium) Tablets to reduce the risk of nonfatal heart attacks, ...

Eliot Brinton, MD, provides a warning concerning “maximally-tolerated statin dosing” and provides general guidance for optimal dosing. Eliot Brinton, MD: One of the mantras that we’ve had for many ...

New York, NY - The Food and Drug Administration (FDA) has approved the expanded use of atorvastatin (Lipitor, Pfizer) to include patients at high risk for cardiovascular conditions because of prior MI ...

People with type 2 diabetes who started taking statins lived longer than those who did not, even when their predicted risk of ...

Your doctor has suggested you give statins a try to help lower your cholesterol levels, but you're worried about the side ...

A new study suggests that statins may activate inflammatory "danger signals" inside muscle cells, leading to weakness and muscle loss in susceptible individuals.

NEW YORK--(BUSINESS WIRE)--Pfizer Inc (NYSE:PFE) announced it has submitted pediatric data for Lipitor® (atorvastatin) to the European Medicines Agency (EMEA). Pfizer has also developed a new chewable ...

A new study reveals how statins may trigger muscle pain and weakness by activating inflammatory pathways, offering clues to ...

Two new studies published this week highlight the successes, as well as the disappointments, in the battle to get patients to take a high-intensity statin for secondary prevention. In the “good news” ...

Lipitor Receives FDA Approval for Five New Indications in Patients With Heart Disease NEW YORK, March 7 -- Pfizer announced today that the U.S. Food and Drug Administration (FDA) has approved ...